Evidence map›Paper›PMID 41784019›Full record

ArticleHaematologica2026

Bleomycin omission in limited-stage classic Hodgkin lymphoma with negative PET scan after two cycles of ABVD.

Jiayu Yang, Diego Villa, Alina S Gerrie, R Petter Tonseth, Don C Wilson, François Bénard, Graham W Slack, Christopher P Venner, Andrea C Lo, David W Scott and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jiayu YangDivision of Medical Oncology, University of British Columbia, Vancouver, BC, Canada.
Diego VillaDivision of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Alina S GerrieDivision of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
R Petter TonsethDepartment of Radiology, University of British Columbia, Vancouver, BC, Canada.
Don C WilsonDepartment of Radiology, University of British Columbia, Vancouver, BC, Canada.
François BénardDepartment of Radiology, University of British Columbia, Vancouver, BC, Canada.
Graham W SlackCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada; Department of Pathology, University of British Columbia, Vancouver, BC, Canada.
Christopher P VennerDivision of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Andrea C LoCentre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada; Department of Radiation Oncology, University of British Columbia, Vancouver, BC, Canada.
David W ScottDivision of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Laurie H SehnDivision of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada.
Kerry J SavageDivision of Medical Oncology, University of British Columbia, Vancouver, BC, Canada; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada. ksavage@bccancer.bc.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41784019
PMCPMC13482219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.